Oppenheimer Asset Management Inc. lowered its stake in shares of Transcat, Inc. (NASDAQ:TRNS – Free Report) by 1.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,391 shares of the scientific and technical instruments company’s stock after selling 191 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Transcat were worth $1,158,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently bought and sold shares of the company. Diversified Trust Co lifted its holdings in Transcat by 4.3% during the fourth quarter. Diversified Trust Co now owns 2,435 shares of the scientific and technical instruments company’s stock worth $266,000 after buying an additional 100 shares during the period. Arizona State Retirement System increased its position in shares of Transcat by 11.9% during the fourth quarter. Arizona State Retirement System now owns 2,434 shares of the scientific and technical instruments company’s stock worth $266,000 after purchasing an additional 258 shares in the last quarter. Howe & Rusling Inc. acquired a new position in shares of Transcat during the fourth quarter worth $385,000. Linden Thomas Advisory Services LLC increased its position in shares of Transcat by 26.9% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 3,841 shares of the scientific and technical instruments company’s stock worth $420,000 after purchasing an additional 814 shares in the last quarter. Finally, New York State Common Retirement Fund increased its position in shares of Transcat by 34.6% during the fourth quarter. New York State Common Retirement Fund now owns 3,963 shares of the scientific and technical instruments company’s stock worth $433,000 after purchasing an additional 1,019 shares in the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.
Insider Buying and Selling
In related news, Director Charles P. Hadeed sold 1,358 shares of Transcat stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $130.00, for a total transaction of $176,540.00. Following the completion of the sale, the director now owns 21,320 shares of the company’s stock, valued at $2,771,600. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Transcat news, insider James M. Jenkins sold 5,514 shares of the business’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $137.18, for a total value of $756,410.52. Following the completion of the transaction, the insider now directly owns 1,619 shares of the company’s stock, valued at $222,094.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Charles P. Hadeed sold 1,358 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $130.00, for a total value of $176,540.00. Following the completion of the transaction, the director now directly owns 21,320 shares of the company’s stock, valued at $2,771,600. The disclosure for this sale can be found here. Insiders sold 22,215 shares of company stock valued at $2,969,084 over the last quarter. 4.20% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
View Our Latest Report on TRNS
Transcat Trading Up 3.8 %
Transcat stock opened at $129.58 on Monday. The company has a quick ratio of 2.62, a current ratio of 3.14 and a debt-to-equity ratio of 0.01. Transcat, Inc. has a 52 week low of $81.59 and a 52 week high of $147.00. The company has a market capitalization of $1.18 billion, a price-to-earnings ratio of 81.50 and a beta of 0.68. The stock has a 50-day moving average price of $123.77 and a 200 day moving average price of $112.89.
Transcat (NASDAQ:TRNS – Get Free Report) last released its earnings results on Monday, May 20th. The scientific and technical instruments company reported $0.77 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.25. Transcat had a return on equity of 9.50% and a net margin of 5.26%. The firm had revenue of $70.91 million during the quarter, compared to the consensus estimate of $68.76 million. Sell-side analysts anticipate that Transcat, Inc. will post 1.99 EPS for the current year.
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
See Also
- Five stocks we like better than Transcat
- Stock Dividend Cuts Happen Are You Ready?
- CPI Data Sparks Rally in Biotech Stocks
- How to Invest in the FAANG Stocks
- High Call Option Volume: 3 Stocks to Keep on Your Radar
- Financial Services Stocks Investing
- Positive News is Driving This Cancer Drug Maker’s Stock Higher
Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.